Trials / Completed
CompletedNCT03754842
Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans
Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans - A Randomized, Placebo-controlled, Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 55 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Successful skeletal muscle regeneration depends on a functional pool of muscle stem cells, termed satellite cells (SC). SC are in a quiescent state throughout adulthood, but undergo multiple cycles of proliferation and self-renewal in response to muscle damage. During aging, there is a loss of SC quiescence, and SC more readily enter an ageing-state impairing their function. Animal studies have revealed a common denominator for increasing SC function and activity, namely Sirtuin activation. Natural stimulators of Sirtuins includes Nicotinamide Riboside (NR) (a Nicotinamide adenine dinucleotide (NAD+) precursor) and the polyphenol Pterostilbene (PT). In this study, we aim to investigate if NR+PT supplementation will promote skeletal muscle regeneration after muscle damage in elderly humans by enhanced recruitment of SC.
Detailed description
14 days after start of placebo or NR/PT (500/100 mg twice daily) supplementation a muscle damage will induced in the m. vastus lat. by electric stimulation combined with eccentric work in a dynamometer. Muscle biopsies will be collected at 2 hours, 2, 8 and 30 days post damage and placebo or NR/PT supplementation will continue for the whole study period (45 days).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Placebo (twice daily) | Matching placebo |
| OTHER | Nicotinamide Riboside/Pterostilbene (500 mg/100 mg twice daily) | Elysium Basis TM, Elysium Health, Inc., NY, USA |
Timeline
- Start date
- 2019-02-12
- Primary completion
- 2020-09-01
- Completion
- 2020-09-01
- First posted
- 2018-11-27
- Last updated
- 2020-11-05
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03754842. Inclusion in this directory is not an endorsement.